Join
Live feed
·
INSIDERFilingvia Quantisnow
Solid Biosciences Inc. logo

Director Kahn Clare bought $9,924 worth of shares (1,860 units at $5.34), increasing direct ownership by 169% to 2,960 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SLDB· Solid Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLDB (Solid Biosciences Inc.) and more on Quantisnow.